Disclosure Of Entity's Operating Segments [Text Block]

Isofol Medical - Filing #689616

Concept	As at 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	2022-01-01 to 2022-12-31	As at 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31	2021-01-01 to 2021-12-31
Disclosure of entity's operating segments [text block]	—	—		—	—	—	—	—	—	—
Disclosure of operating segments [text block]	—	—	—	—	—	—	—	—	—	—
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue	—	—	12 797 SEK	—	—	—	—	—	22 407 SEK	—
Depreciation and amortisation expense	—	—	1 642 SEK	—	—	—	—	—	1 596 SEK	—
Tax expense (income)	—	—	- SEK	—	—	—	—	—	- SEK	—
Profit (loss) before tax	—	—	159 755 SEK	—	—	—	—	—	200 251 SEK	—
Profit (loss)	—	- SEK	159 755 SEK	- SEK	159 755 SEK	—	- SEK	- SEK	200 251 SEK	200 251 SEK
Assets	213 464 SEK	—	—	—	—	401 363 SEK	—	—	—	—
Liabilities	54 985 SEK	—	—	—	—	83 130 SEK	—	—	—	—
Cash flows from (used in) operating activities	—	—	190 975 SEK	—	—	—	—	—	188 429 SEK	—
Cash flows from (used in) investing activities	—	—	- SEK	—	—	—	—	—	- SEK	—
Cash flows from (used in) financing activities	—	—	1 681 SEK	—	—	—	—	—	450 477 SEK	—
Disclosure of products and services [text block]	—	—	—	—	—	—	—	—	—	—
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]	—	—	—	—	—	—	—	—	—	—
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]	—	—	—	—	—	—	—	—	—	—
Disclosure of major customers [abstract]
Disclosure of major customers [line items]